Literature DB >> 6411919

A clinical study of older age rheumatoid arthritis with comparison to a younger onset group.

R Terkeltaub, J Esdaile, F Décary, H Tannenbaum.   

Abstract

The clinical features, therapy and course of disease in a group of 34 patients with older age onset rheumatoid arthritis (ORA) defined as disease onset after age 60 are compared with a group of 34 rheumatoid patients whose disease onset began at a younger age (YRA). Onset of rheumatoid arthritis (RA) beyond age 60 is not uncommon as ORA represented 33% of all RA patients seen in our rheumatic disease unit. The ORA patients had a shorter mean disease duration (p less than 0.001) and a tendency to less rheumatoid factor seropositivity (p = 0.06) despite random selection for active disease of less than 10 years' duration. Suppressive therapy was employed less frequently in ORA (p less than 0.01) than in YRA but the use of other therapeutic modalities and the last recorded functional class were similar in the 2 groups. ORA patients did have greater functional incapacity at some point in their disease course (p less than 0.01) as well as a greater frequency of weight loss (p less than 0.001) and other acute systemic features at onset than YRA patients. Seronegative ORA appeared to have a favourable disease course in comparison with seropositive ORA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411919

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Rheumatoid arthritis in Greece. Manifestations in different age groups.

Authors:  A P Andonopoulos; V Galanopoulou; A A Drosos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

Review 2.  An autumn tale: geriatric rheumatoid arthritis.

Authors:  Senol Kobak; Cemal Bes
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-07       Impact factor: 5.346

Review 3.  Rheumatoid arthritis in the elderly. Prevalence and optimal management.

Authors:  D van Schaardenburg
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 4.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Early rheumatoid arthritis--onset, course, and outcome over 2 years.

Authors:  K B Eberhardt; L C Rydgren; H Pettersson; F A Wollheim
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study.

Authors:  T R Mikuls; K G Saag; L A Criswell; L A Merlino; R A Kaslow; B J Shelton; J R Cerhan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

7.  Outcome of late-onset rheumatoid arthritis.

Authors:  Jaime Calvo-Alén; Alfonso Corrales; Sagrario Sánchez-Andrada; Maria Antonia Fernández-Echevarría; Jose L Peña; Vicente Rodríguez-Valverde
Journal:  Clin Rheumatol       Date:  2005-03-05       Impact factor: 2.980

8.  Differences in anti-Fab antibodies in adult and late onset rheumatoid arthritis.

Authors:  F Gamerith; G J Zlabinger; O Scherak; G Kolarz; M Schemper; H Heinzl; J E Menzel
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

Review 9.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

Review 10.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.